Home › Trial NCT01202786
Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)
- Trial IDNCT01202786
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorTeva Branded Pharmaceutical Products R&D, Inc.
- Enrollment60
- Start date2010-05
- ConditionsNeoplasms, Unknown Primary
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.